Clinical Trial

A Single-dose Study to Evaluate the Safety, Tolerability, Drug Levels, and Relative Biological Availability of Alternate Formulations of BMS-986460 in Healthy Adult Male Participants

Completed Phase 1
View on ClinicalTrials.gov →
Summary
The purpose of this study is to assess the safety, tolerability, drug levels, and relative bioavailability of alternate formulations of BMS-986460 in healthy adult male participants.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2025-03-10; most recent amendment 2026-01-16.
Status change: Recruiting → Completed 2026-01-16
Status change: Not Yet Recruiting → Recruiting 2025-04-10
Trial Details
NCT Number NCT06877702
Lead Sponsor Bristol-Myers Squibb
Conditions Healthy Volunteers
Enrollment 85 participants
Start Date 2025-03-19
Primary Completion 2025-12-17 (estimated)
Study Completion 2025-12-17 (estimated)
Updated on ClinicalTrials.gov 2026-01-20